RECRUITINGOBSERVATIONAL
An International Study on Pediatric Patients With Rare Tumors.
The PARTNER Study - An International Prospective Observational Study on Pediatric Patients With Very Rare Tumors.
About This Trial
The PARTNER study is an international, prospective, observational study of paediatric patients with very rare tumours.
Who May Be Eligible (Plain English)
Who May Qualify:
- Children and adolescents (age 0-18 years) with a primary or relapsed Very Rare Tumor diagnosed and/or treated in a participating country/center.
- Written willing to sign a consent form from the patient and/or the parent/legal guardian
Who Should NOT Join This Trial:
- Absence of Written willing to sign a consent form from the patient and/or the parent/legal guardian
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Children and adolescents (age 0-18 years) with a primary or relapsed Very Rare Tumor diagnosed and/or treated in a participating country/center.
* Written informed consent from the patient and/or the parent/legal guardian
Exclusion Criteria:
* Absence of Written informed consent from the patient and/or the parent/legal guardian
Locations (1)
Pediatric Oncology Unit, University Hospital Padova [AOUP Azienda Ospedale Università Padova]
Padova, Italy, Italy